Full-Time
Master Data Expert
Finance
Opella
5,001-10,000 employees
Global OTC & VMS self-care manufacturer
No salary listed
Hyderabad, Telangana, India
In Person
Bachelor's
 Accounting (1) |
|---|
Get referred to Opella
See people who can refer or advise you
- A bachelor's degree in Finance, Accounting, Information Technology, Computer Science, Engineering, Business Administration, or a related field.
- At least 10 years of experience in SAP, Finance Master Data, master data management, or enterprise applications.
- Strong techno-functional experience with SAP Master Data Governance for Financials.
- Experience leading or supporting at least one full-cycle SAP MDG Finance implementation.
- Strong understanding of SAP FI and SAP CO processes and master data.
- Hands-on experience configuring SAP MDG, including change requests, workflow, data models, validations, derivations, and user interfaces.
- Experience with BRFplus and rule-based workflow.
- Experience with the Data Replication Framework and SAP master data replication.
- Understanding of ABAP concepts and the ability to work effectively with ABAP development teams.
- Experience defining Business Add-Ins, enhancements, interfaces, custom validations, and technical specifications.
- Experience with SAP ECC and/or SAP S/4HANA.
- Experience with master data migration, data mapping, cleansing, validation, and reconciliation.
- Strong understanding of data governance, data ownership, stewardship, and data-quality principles.
- Experience working with integrations, APIs, IDocs, web services, or middleware platforms.
- Strong troubleshooting and root-cause analysis skills.
- Experience working in global transformation or multi-country implementation programs.
- Strong communication, facilitation, documentation, and stakeholder-management skills.
- Ability to communicate effectively with both business and technical stakeholders.
- Lead the techno-functional design and implementation of SAP MDG for Finance Master Data.
- Serve as the primary subject matter expert for SAP MDG-F across business process, functional design, configuration, workflow, data model, and integration areas.
- Translate Finance and Data Governance requirements into scalable SAP MDG solution designs.
- Lead current-state assessments, fit-gap analysis, future-state process design, solution architecture, configuration, testing, deployment, and stabilization.
- Ensure the SAP MDG solution aligns with Finance transformation objectives, enterprise architecture standards, and the SAP S/4HANA roadmap.
- Review technical and functional designs produced by internal teams and implementation partners.
- Identify opportunities to use standard SAP MDG capabilities and minimize unnecessary customization.
- Provide techno-functional expertise across Finance Master Data domains, including general ledger accounts, chart of accounts, cost centers, profit centers, company codes, business areas, functional areas, internal orders, financial hierarchies, consolidation-related master data, and Finance reference data and organizational structures.
- Define global data standards, field definitions, naming conventions, validation requirements, and lifecycle rules.
- Support the harmonization of Finance Master Data across countries, business units, and ERP platforms.
- Ensure alignment between master data structures and global Finance business processes.
- Configure and enhance SAP MDG Finance processes, including change request types, workflow steps and approval routing, user interfaces, business activities, data models, entity types, relationships, field properties, validations and derivations, duplicate checks, search capabilities, number ranges, and edition and hierarchy management.
- Configure SAP MDG Business Rule Framework Plus for validations, derivations, and workflow routing.
- Support configuration of Floorplan Manager and SAP MDG user interfaces.
- Design and support custom enhancements using SAP enhancement frameworks when standard functionality is insufficient.
- Work with ABAP developers to define and review Business Add-Ins, enhancement spots, custom classes, workflow agents, user exits, custom validations and derivations, and data replication enhancements.
- Troubleshoot configuration, workflow, data model, and integration issues.
- Perform root-cause analysis and coordinate technical resolution of SAP MDG defects.
- Design end-to-end workflows for Finance Master Data creation, change, extension, blocking, and retirement.
- Configure rule-based workflow routing based on master data type, business unit, geography, risk, and approval authority.
- Define roles for Data Owners, Data Stewards, Finance Process Owners, Shared Services, and Technology teams.
- Implement segregation-of-duties and approval controls within SAP MDG workflows.
- Ensure workflow designs support auditability, regulatory expectations, and internal control requirements.
- Develop escalation, rejection, rework, delegation, and exception-handling processes.
- Support workflow monitoring and continuous optimization.
- Design integration between SAP MDG and SAP S/4HANA, SAP ECC, Central Finance, consolidation, planning, reporting, and downstream applications.
- Configure and support Finance Master Data replication using the Data Replication Framework, IDocs, web services, SAP Application Link Enabling, Remote Function Calls, SAP Integration Suite, and APIs.
- Define replication models, target systems, filters, mappings, and distribution rules.
- Support key mapping and value mapping between source and target systems.
- Troubleshoot replication failures, interface errors, and synchronization issues.
- Collaborate with middleware, integration, and ERP teams to ensure accurate and timely data distribution.
- Ensure approved master data is consistently replicated to all required consuming systems.
- Review and extend the standard SAP MDG Finance data model when required.
- Define custom entities, attributes, relationships, and business rules.
- Assess whether requirements should be addressed through configuration, data model extension, or custom development.
- Ensure data model changes are scalable, supportable, and aligned with enterprise standards.
- Develop clear functional and technical specifications for enhancements.
- Review technical designs, code, and test results with development teams.
- Ensure custom solutions follow SAP best practices and organizational development standards.
- Lead the techno-functional aspects of Finance Master Data migration into SAP MDG and target ERP systems.
- Define source-to-target mappings, transformation rules, data-cleansing requirements, and validation controls.
- Support data extraction, profiling, deduplication, enrichment, conversion, and reconciliation.
- Work with migration teams to design initial-load and mass-upload approaches.
- Support migration using SAP Migration Cockpit, Data Services, custom upload programs, APIs, or other approved tools.
- Validate loaded master data against business and technical acceptance criteria.
- Support mock migrations, cutover rehearsals, production cutover, and post-load reconciliation.
- Resolve data-quality and technical issues discovered during migration cycles.
- Define and implement validation, derivation, completeness, uniqueness, and consistency rules for Finance Master Data.
- Ensure rules are implemented at the appropriate stage of the SAP MDG process.
- Support integration with enterprise data-quality and data-governance tools where applicable.
- Define data-quality KPIs and operational monitoring reports.
- Identify recurring data issues and recommend preventive controls.
- Ensure Finance Master Data supports audit, compliance, and financial-control requirements.
- Partner with Data Governance teams to align SAP MDG with enterprise policies and standards.
- Define the SAP MDG Finance testing strategy and test coverage.
- Lead or support unit testing, functional testing, system integration testing, user acceptance testing, regression testing, performance testing, and security testing.
- Develop detailed test scenarios for workflows, validations, derivations, data replication, hierarchy management, and exception handling.
- Coordinate defect triage and resolution across functional, technical, integration, and business teams.
- Support transport management and deployment across development, quality, and production environments.
- Lead cutover planning and go-live readiness activities.
- Provide post-go-live support and stabilization.
- Define SAP MDG roles and authorization requirements in collaboration with SAP Security teams.
- Ensure users have appropriate access based on their responsibilities.
- Support the design of Data Owner, Data Steward, Approver, Requester, Administrator, and Support roles.
- Ensure segregation-of-duties requirements are incorporated into the solution.
- Support authorization testing and resolution of access-related issues.
- Lead the SAP MDG Finance techno-functional workstream across global and regional teams.
- Partner with Finance leaders, Global Process Owners, Data Owners, Data Stewards, architects, developers, and implementation partners.
- Facilitate design workshops and decision-making sessions.
- Manage workstream plans, deliverables, dependencies, risks, issues, and decisions.
- Provide clear status updates to program leadership and senior stakeholders.
- Coordinate onshore, offshore, internal, and vendor resources.
- Review implementation partner deliverables and ensure quality and adherence to agreed standards.
- Mentor SAP MDG consultants, analysts, developers, and Data Stewards.
- Develop and maintain solution design documents, functional specifications, technical specifications, configuration documents, data model documentation, workflow designs, interface specifications, test scripts, operating procedures, and support documentation.
- Create training materials and user guides.
- Conduct knowledge-transfer sessions for Finance users, Data Stewards, SAP support teams, and administrators.
- Support the transition of the implemented solution to application maintenance and support teams.
- SAP certification in SAP MDG, SAP S/4HANA Finance, SAP FI/CO, or a related area.
- Experience in healthcare, consumer healthcare, pharmaceutical, medical device, or life sciences organizations.
- Experience with SAP Central Finance or SAP Group Reporting.
- Experience with SAP Fiori and SAP Business Workflow.
- Knowledge of Floorplan Manager and Web Dynpro applications.
- Experience with SAP Integration Suite, SAP Process Integration, SAP Process Orchestration, or similar middleware technologies.
- Understanding of SAP MDG consolidation and mass-processing capabilities.
- Experience with cloud data-governance, metadata-management, or data-quality platforms.
- Familiarity with Informatica data governance or data quality solutions.
- Experience implementing SAP MDG in a regulated environment.
- Experience working with Global Business Services or Finance Shared Services.
- Experience managing implementation partners and offshore delivery teams.
- Familiarity with SAP Activate, Agile, Scrum, or hybrid delivery methodologies.
Opella produces over-the-counter medicines, vitamins, minerals and supplements for a global audience, with about 100 brands and 11,000 employees. Its products are ready-to-use self-care remedies sold without prescription, covering needs like pain relief, digestion and allergy relief. The company differentiates itself through a large global manufacturing footprint (13 sites) and dedicated science and innovation centers, plus its status as a certified B Corp focused on health for people and the planet. Its goal is to simplify self-care, putting health in people’s hands for half a billion consumers and growing its trusted portfolio through manufacturing excellence and science-backed development.
Company Size
5,001-10,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Neuilly-sur-Seine, France
Founded
2018
Get referred to Opella
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 2026 Mexico line adds 200 million mini-bottles, lifting local manufacture to 80%.
- March 2026 FIP partnership strengthens pharmacist influence and supports self-care adoption.
- February 2026 Australia electrification funding cuts gas use and lowers operating emissions.
What critics are saying
- Americans reach shelves only in 2027-2028, delaying Mexico expansion payback and execution.
- Opella still relies on Sanofi-era shared branding, while ownership remains split with CD&R.
- Any Enterogermina validation failure at Ocoyoacoyoc freezes Americas supply and damages flagship probiotic sales.
What makes Opella unique
- April 30, 2025: CD&R and Sanofi made Opella an independent consumer-health leader.
- Opella owns 100 brands, 11,000 employees, and 13 manufacturing sites globally.
- July 2026: Mexico makes Enterogermina API and finished product, a rare capability.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↑ 75%1 year growth
↑ 75%2 year growth
↑ 26%Karan Bhatia joins Asahi Group as director-agps. Karan Bhatia has transitioned from Sanofi and Opella to join Asahi Group as Director-AGPS. Announcing the move on LinkedIn, he reflected on closing a nine-year chapter with the two organisations, expressing gratitude for the experiences and opportunities gained during his tenure. Karan Bhatia has embarked on a new professional journey, joining Asahi Group as Director-AGPS after nearly a decade with Sanofi and its subsidiary Opella. The development was shared by Bhatia in a LinkedIn update, where he confirmed his departure from the pharmaceutical giant and expressed appreciation for the formative years he spent across the two organisations. "Last week, I closed a professional chapter of nine years with Sanofi & Opella. I'm grateful for my time in these two world-class organisations," he wrote, signalling both the end of a significant tenure and the beginning of a fresh chapter with Asahi Group. Bhatia's move marks a notable shift from the healthcare and pharmaceutical sector to the global beverage industry, underscoring the breadth of his professional expertise and adaptability. Sanofi, a multinational pharmaceutical company headquartered in Paris, and Opella, its consumer healthcare arm, provided him with a platform to contribute to diverse markets and complex business environments. His nine-year association with the two companies reflects a period of sustained growth and leadership, during which he played a role in advancing business strategies and operational excellence. The transition to Asahi Group, a leading Japanese beverage and food company with a strong international footprint, positions Bhatia within a dynamic sector known for innovation and global consumer engagement. As Director-AGPS, he is expected to bring his extensive experience in corporate leadership, strategic planning and cross-sectoral collaboration to strengthen Asahi's global operations. Industry observers note that such cross-sectoral moves are increasingly common among senior executives, reflecting the convergence of skills required across industries. Bhatia's background in healthcare and pharmaceuticals equips him with a unique perspective on consumer needs, regulatory frameworks and international business practices, which are highly relevant to the fast-evolving beverage industry. His announcement has drawn attention within professional circles, with peers and colleagues acknowledging his contributions to Sanofi and Opella while extending best wishes for his new role. The move also highlights the growing trend of leaders leveraging their expertise across diverse industries to drive transformation and growth. For Asahi Group, the appointment underscores its commitment to strengthening leadership capabilities and enhancing its global strategy. For Bhatia, it represents both continuity and change: continuity in his pursuit of impactful leadership, and change in embracing new challenges within a different sector. Discover more from creative brands mag. Brand Management Discover more advertising Business Operations Missing Persons & Abductions July 30, 2026 Discover more Shopping Portals
The Week in Health: Hospital investment, Cyclospora Outbreak. By Sergio Arturo Lievano Madrigal | Journalist - Fri, 07/24/2026 - 09:59 DIA assistant Mexico's health sector moved on two fronts this week: public infrastructure spending and private manufacturing investment both accelerated, while a cross-border food safety scare tested coordination with the FDA. Meanwhile, a cholesterol drug approval and an insurtech's growth rounded out a week defined by expanding access to care. Ready? This is the Week in Health! Mexico Unveils MX$181 Billion Hospital Infrastructure Plan The government will invest close to MX$181 billion through 2030 to build, expand, or replace 152 public hospitals, growing the IMSS, ISSSTE, and IMSS Bienestar network past 106,000 beds. The plan responds to long-documented funding disparities across Mexico's fragmented public health subsystems. Mexico Modernizes Public Hospitals as Medical Device Market Grows ISSSTE's MX$298 million investment in electric beds and operating room upgrades coincides with LINET Group's new Santa Fe headquarters, signaling sustained demand for medical equipment. Together, the moves point to a multi-front procurement cycle spanning commodity and specialized devices alike. Mexico Investigates Cyclospora Outbreak Mexican authorities activated a joint task force with the FDA to investigate a cyclospora outbreak linked to lettuce from Guanajuato-based supplier Taylor Farms. The case carries real stakes for Mexico's vegetable export sector, which sends nearly 96% of its output to the United States. FDA Approves Merck Oral Pill for High Cholesterol The US FDA approved Lipfendra, Merck's first-in-class oral PCSK9 inhibitor, aimed at the 70% of statin patients who still miss their cholesterol targets. The approval carries relevance for Mexico, where cardiovascular disease remains a leading cause of mortality. Opella Expands Enterogermina Production Line in State of Mexico Opella inaugurated a MX$1.2 billion production line in Ocoyoacac, part of a MX$2.3 billion plan to raise local manufacturing for the domestic market to 80%. The project positions the site as a global backup facility and is expected to create 500 direct and indirect jobs. Disrupting Mexican Healthcare Through Tech-Driven InsurTech Mutuus' Jean-Louis Brunet tells MBN the insurtech now serves 14,000 members through a zero-deductible, direct-payment model targeting Mexico's underserved middle class. He says recent IVA tax changes forced a 23% workforce cut, even as the company grows more than 40% annually.
Opella inaugurates new $70m-backed production line. Healthcare company Opella has announced that it has inaugurated a new production line for Enterogermina in Mexico following a US$70 million (c. £52m) investment. Reportedly, the highly automated facility in Ocoyoacac will add an annual capacity of 200 million mini-bottles. It will serve as a complementary regional hub to Opella's plant in Origgio, Italy, and will operate on 100% renewable electrical energy. Opella chief supply chain officer, Rafik Amrane, said: "This new production line in Mexico is a crucial step forward in its broader mission to build a highly resilient, global manufacturing network. "By increasing our production capacity and being closer to the markets we serve, we are fundamentally changing how we deliver care, ensuring that our science-backed solutions are consistently available to the millions of families who rely on them." Following rigorous qualification and regulatory approvals, the new production line will progressively scale operations to bring the product to shelves across the Americas in the 2027-2028 period. Opella Mexico general manager, Luis Soares, said: "With this new production line, Logistics Manager is strengthening Mexico's role as a strategic platform for advanced pharmaceutical manufacturing and exports to Latin America. "It will also enable us to increase the share of Opella products sold in Mexico that are locally manufactured from 60% to 80%, combining stronger, sustainable local production with greater regional reach." IntraLogisteX is taking place in Dallas in 2026, bringing the industry's leading trade show & conference to one of North America's most important logistics hubs. Reuben joined Akabo Media as assistant editor of CiTTi - one of Logistics Manager's sister publications - in October 2023. He has worked in digital and print publications since graduating in MA Publishing in 2022. He holds a great interest in transport technology and innovation. Outside of work, Reuben is also a huge football fan. 24th July 2026 21st July 2026
Opella shifts Enterogermina production to Mexico. 23 July, 2026 Opella has transferred production of its flagship probiotic Enterogermina from Italy to Mexico, marking a major milestone in the company's manufacturing strategy for the Americas. The move is supported by a US$70 million investment in a new production line at its Ocoyoacac facility in the State of Mexico, part of a broader US$135 million expansion plan running through 2028. The expansion transforms the Ocoyoacac plant into the company's second global manufacturing hub for Enterogermina, complementing its long-established facility in Origgio, Italy. For the first time, the Mexican site will produce both the active pharmaceutical ingredient and the finished product, bringing advanced manufacturing capabilities that were previously concentrated in Europe. The new production line adds an annual capacity of 200 million mini-bottles, enabling Opella to meet growing demand across Latin America while strengthening the resilience of its global supply network. Company executives said producing closer to key markets will improve supply chain efficiency and support faster regional distribution. As production ramps up, the share of Opella products sold in Mexico that are manufactured locally will increase from 60% to 80%. The company also expects the facility to play a larger role as an export platform, supplying multiple Latin American markets from Mexico. Beyond expanding manufacturing capacity, the investment includes a significant transfer of industrial expertise and production technology. According to the company, the project equips the Mexican operation with specialized know-how and quality systems required to manufacture one of the world's leading probiotic brands under the same standards applied in Europe. The Ocoyoacac facility also supports Opella's sustainability objectives. The site operates with 100% renewable electricity, has significantly reduced carbon emissions over the past several years, and follows a zero-waste-to-landfill model, aligning manufacturing expansion with the company's environmental commitments. With the relocation of Enterogermina production, Mexico assumes a more strategic role within Opella's global manufacturing network, reinforcing the country's position as an emerging pharmaceutical production and export hub for the Americas.
Opella appoints Radu Stănescu as Country Head Romania & Moldova. Published on July 23, 2026 Opella, the consumer healthcare company with the third-largest portfolio in the Over the Counter (OTC) and Vitamins, Minerals & Supplements (VMS) market globally, announces the appointment of Radu Stănescu as Country Head for Romania & Moldova. Radu Stănescu brings extensive commercial leadership experience from multinational organizations, including Beiersdorf and Reckitt. Radu Stănescu, Country Head for Romania & Moldova at Opella: "Together with our team, I look forward to building on the strong foundations already in place, serving consumers across Romania and Moldova through our loved brands and working closely with healthcare professionals to empower people to choose health and self-care brands with confidence." In Romania and Moldova, Opella serves consumers with a broad portfolio of health and self-care solutions, including OTC medicines as well as food supplement brands such as Enterogermina and MagneVie. Post Views: 14,698 The first Cobra II tactical armoured vehicles built entirely in Mediaș left the factory... July 24, 2026 PPC Group's entry into the Hungarian energy market, one of Europe's fastest-growing clean energy... July 24, 2026 TeraPlast Group inaugurated its TeraPlast Iberia polyethylene pipe factory in Spain, an important step... July 24, 2026 Rețele Electrice România, part of the PPC group in Romania, has completed the modernization... July 24, 2026 The first Cobra II tactical armoured vehicles built entirely in Mediaș left the factory... July 24, 2026 PPC Group's entry into the Hungarian energy market, one of Europe's fastest-growing clean energy... July 24, 2026 TeraPlast Group inaugurated its TeraPlast Iberia polyethylene pipe factory in Spain, an important step... July 24, 2026